Our Co-founder & Managing Director featured as one of the 10 MOST SUCCESSFUL HEALTHCARE ENTREPRENEURS REVAMPING THE PHARMACEUTICAL INDUSTRY WORLDWIDE in a leading magazine ‘Healthcare Insights” Healthcare Insights recognizes Pharma Solutions as one such company that provides an effective platform for innovative pharmaceutical and healthcare companies, who are keen to venture into the emerging market […]
Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China. It was initially reported to the World Health Organization (WHO) on December 31, […]
A recent study led by researchers at the Virginia Commonwealth University (VCU) Massey Cancer Center found strong evidence that prolactin, a hormone responsible for breast growth and production of milk during pregnancy acts as a major contributor to breast cancer development and that the hormone could inform the creation of targeted drugs to treat multiple […]
On April Pharma Solutions started negotiations with MSN on the way forward for mutual collaboration and business partnership MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine Active Pharmaceutical Ingredients (API) and five finished dosage […]
Most firms have set up a war room to triage their immediate response to the crisis. But the lack of visibility around future demand complicates efforts to restart stalled portfolio companies…
Most firms have set up a war room to triage their immediate response to the crisis. But the lack of visibility around future demand complicates efforts to restart stalled portfolio companies…
Most firms have set up a war room to triage their immediate response to the crisis. But the lack of visibility around future demand complicates efforts to restart stalled portfolio companies…
We have the pleasure to announce the UAE Ministry of Health & Prevention (MoHAP) approval for; Ricovir-EM® (tenofovir/emtricitabine) 300mg/200mg film-coated Tablets, 30s HDPE bottle Ricovir-EM® is a double combination therapy for the treatment of HIV-1 infected adults. Mylan is committed to manufacturing low-cost, high-quality generics thus contributing to affordable healthcare. Mylan is also involved in […]
We are pleased to announce Pharma Solutions exclusive partnership with Aurobindo Pharma, one of the largest Pharmaceutical companies in India with a global footprint. Pharma Solutions will exclusively market & distribute Aurobindo Oncology products in key treatment centers in the UAE.